Cite
HARVARD Citation
Islam, I. et al. (2018). Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorganic & medicinal chemistry letters. 28 (20), pp. 3372-3375. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Islam, I. et al. (2018). Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorganic & medicinal chemistry letters. 28 (20), pp. 3372-3375. [Online].